Cancer Prevention Group’s Christmas reading list
As the year draws to an end, we have been looking back and reflecting on the groups achievements in 2019. We decided that the best […]
medical research
Screening iconoclasm series: Are you putting too much value on positive predictive value?
If you read the previous blog from the screening iconoclast and know a little about screening, you might be thinking that the thing to do […]
Screening iconoclasm series: Don’t be overly sensitive about sensitivity
In this post, Peter Sasieni argues that sensitivity is over-rated. It is the first of a series of posts on “Screening Iconoclasm” in which we […]
Consent in clinical trials
Is it ethical to enrol patients into a clinical trial without first obtaining their consent? Most people’s immediate reaction is “No”. But what should people […]
Doug Altman – A Giant Among Statisticians
I’m sure there will be many obituaries over the coming days, and if you want a synopsis of Professor Altman’s accomplishments you can read his […]
Data protection versus health protection
On 25th of May 2018 the EU General Data Protection Regulation (GDPR) went live. GDPR is designed to protect EU citizens from organisations using their data […]